戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 racellular signal-related kinase), and VASP (vasodilator-stimulated phosphoprotein).
2 ated with increased mRNA expression of VASP (vasodilator-stimulated phosphoprotein).
3 e highly related to Enabled as well as VASP (Vasodilator-Stimulated Phosphoprotein).
4  as an established protein substrate of PKG (vasodilator-stimulated phosphoprotein).
5 arinic-induced phosphorylation of Ser-239 in vasodilator-stimulated phosphoprotein.
6 ng mislocalization of the TJ binding protein vasodilator-stimulated phosphoprotein.
7  activation of cofilin 1 and inactivation of vasodilator-stimulated phosphoprotein.
8 al nitric oxide synthase, and phosphorylated vasodilator-stimulated phosphoprotein.
9 y VerifyNow and platelet reactivity index by vasodilator-stimulated phosphoprotein.
10 lls and increases the phosphorylation of the vasodilator-stimulated phosphoprotein.
11 ne of these clones was found to encode VASP (vasodilator-stimulated phosphoprotein), a previously ide
12 ICAM-1, and decreased phosphorylation of the vasodilator-stimulated phosphoprotein, a marker for nitr
13  of isoproterenol-induced phosphorylation of vasodilator-stimulated phosphoprotein, a membrane cytosk
14                       Zyxin in turn recruits vasodilator-stimulated phosphoprotein, a regulator of ac
15 actin and associated cellular proteins, like vasodilator-stimulated phosphoprotein, adjacent to the a
16 ficantly reduced phosphorylation of platelet vasodilator-stimulated phosphoprotein, an indicator of N
17 3 exposure also led to the redistribution of vasodilator-stimulated phosphoprotein, an NO regulated p
18 A2beta-null cells potentiates Ang II-induced vasodilator-stimulated phosphoprotein and Akt phosphoryl
19 ost actin-regulatory layer containing zyxin, vasodilator-stimulated phosphoprotein and alpha-actinin.
20  partners alpha-actinin and p130Cas, but not vasodilator-stimulated phosphoprotein and cysteine-rich
21 ted exaggerated levels of phosphorylation of vasodilator-stimulated phosphoprotein and extracellular
22 eton-associated proteins including mammalian vasodilator-stimulated phosphoprotein and murine Enabled
23 thromboxane A(2) significantly decreased and vasodilator-stimulated phosphoprotein and nitric oxide i
24 ostanes, and thromboxane A(2), and increased vasodilator-stimulated phosphoprotein and nitric oxide.
25 tivate PKG as measured by phosphorylation of vasodilator-stimulated phosphoprotein, and by in vitro k
26 Enabled, phosphorylated (p)-cortactin, and p-vasodilator-stimulated phosphoprotein, and increased act
27 care P2Y(12) platelet-reactivity test, and a vasodilator-stimulated phosphoprotein assay.
28 sured by light transmittance aggregometry or vasodilator-stimulated phosphoprotein assays, was numeri
29  associated with fascin along the length and vasodilator-stimulated phosphoprotein at the tip.
30 elin-1 may involve Ca(2+), cytoskeleton, and vasodilator-stimulated phosphoprotein changes mediated b
31 encies in actin cytoskeletal organization of vasodilator-stimulated phosphoprotein-containing lamelli
32 ted proteins including pVASP (phosphorylated vasodilator stimulated phosphoprotein), cortactin and vi
33                                  The Enabled/vasodilator-stimulated phosphoprotein (Ena/VASP) family
34                           Drosophila enabled/vasodilator-stimulated phosphoprotein (Ena/VASP) homolog
35                                      Enabled/Vasodilator-stimulated phosphoprotein (Ena/VASP) protein
36                                      Enabled/vasodilator-stimulated phosphoprotein (Ena/VASP) protein
37                              We used Enabled/vasodilator-stimulated phosphoprotein (Ena/VASP)-deficie
38 pendent exocytosis of the late endosome in a vasodilator-stimulated phosphoprotein envelope.
39 ruits host cell Arp2/3 complexes and enabled/vasodilator-stimulated phosphoprotein family members to
40 ave examined the function of a member of the vasodilator-stimulated phosphoprotein family of proteins
41 equently was shown to be a member of the Ena/vasodilator-stimulated phosphoprotein family of proteins
42 eletal regulatory proteins of the Mena/VASP (vasodilator-stimulated phosphoprotein) family.
43 in in response to S-nitrosylation, including vasodilator-stimulated phosphoprotein, focal adhesion ki
44 ion occurs because of associations involving vasodilator-stimulated phosphoprotein, focal adhesion ki
45 ion occurs because of associations involving vasodilator-stimulated phosphoprotein, focal adhesion ki
46 es the rapid zyxin-dependent mobilization of vasodilator-stimulated phosphoprotein from focal adhesio
47 nitiation was the gradual coalescence of GFP-vasodilator-stimulated phosphoprotein (GFP-VASP) fluores
48 tions between the C-terminal EVH1 (Ena/VASP [vasodilator-stimulated phosphoprotein] homology domain 1
49 sphate receptor blockade was assessed by the vasodilator-stimulated phosphoprotein index.
50 hidonoyl glycerol-induced phosphorylation of vasodilator-stimulated phosphoprotein is mediated by cAM
51      Pharmacodynamic assessments measured by vasodilator-stimulated phosphoprotein, light transmittan
52 different assays, including VerifyNow P2Y12, vasodilator-stimulated phosphoprotein, light transmittan
53 TPase, peroxisomal farnesylated protein, Ena/vasodilator-stimulated phosphoprotein-like protein, alph
54 let Nox2, Rac1, p47(phox), protein kinase C, vasodilator-stimulated phosphoprotein, nitric oxide, and
55 n) and biochemically (the phosphorylation of vasodilator-stimulated phosphoprotein, or P-VASP).
56              The APC was not correlated with vasodilator-stimulated phosphoprotein (p = 0.16).
57  the induction of (protein kinase A) phospho-vasodilator-stimulated phosphoprotein (p-VASP) by isopro
58                                 On-treatment vasodilator stimulated phosphoprotein P2Y(12) platelet r
59              Pharmacodynamic end-points were vasodilator-stimulated phosphoprotein P2Y(12) platelet r
60 d or prevented by postsynaptic expression of vasodilator-stimulated phosphoprotein phospho-mimetic or
61 al cyclic adenosine monophosphate (cAMP) and vasodilator-stimulated phosphoprotein phosphorylation (V
62                                Inhibition of vasodilator-stimulated phosphoprotein phosphorylation an
63 d IPA was lower and P2Y12 reaction units and vasodilator-stimulated phosphoprotein phosphorylation an
64                  In contrast, Ang II-induced vasodilator-stimulated phosphoprotein phosphorylation an
65 d significant positive correlations with the vasodilator-stimulated phosphoprotein phosphorylation as
66  5 and 20 mumol/l and arachidonic acid), and vasodilator-stimulated phosphoprotein phosphorylation as
67 (P2Y12 assay) and platelet reactivity index (vasodilator-stimulated phosphoprotein phosphorylation as
68 PD was assessed by using VerifyNow P2Y12 and vasodilator-stimulated phosphoprotein phosphorylation as
69 denosine diphosphate, VerifyNow P2Y(12), and vasodilator-stimulated phosphoprotein phosphorylation as
70 Ialpha in H9c2 and C2C12 cells, we monitored vasodilator-stimulated phosphoprotein phosphorylation do
71 to dense granules, as confirmed by increased vasodilator-stimulated phosphoprotein phosphorylation in
72 e aggregometry, VerifyNow P2Y(12) assay, and vasodilator-stimulated phosphoprotein phosphorylation in
73 GP) IIb/IIIa after stimulation with ADP, and vasodilator-stimulated phosphoprotein phosphorylation le
74 e cells), we were unable to detect increased vasodilator-stimulated phosphoprotein phosphorylation un
75  and PKA, as determined by Rap1 activity and vasodilator-stimulated phosphoprotein phosphorylation, r
76 atment of the cells with kinetics similar to vasodilator-stimulated phosphoprotein phosphorylation.
77  h using light transmission aggregometry and vasodilator-stimulated phosphoprotein phosphorylation.
78  production, cGMP synthesis, and PKG-induced vasodilator-stimulated phosphoprotein phosphorylation.
79 e aggregometry, VerifyNow P2Y(12) assay, and vasodilator-stimulated phosphoprotein phosphorylation.
80 ith different agonists as well as changes in vasodilator-stimulated phosphoprotein platelet reactivit
81 esidual platelet aggregation, p = 0.005) and vasodilator-stimulated phosphoprotein platelet reactivit
82 icantly reduced the effect of clopidogrel on vasodilator-stimulated phosphoprotein platelet reactivit
83 y Artery Bypass Graft (APTITUDE-CABG) study, vasodilator-stimulated phosphoprotein-platelet reactivit
84 e shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin
85 the actin-associated proteins alpha-actinin, vasodilator-stimulated phosphoprotein, profilin, Eps8, a
86 ogaster Enabled (Ena) is a member of the Ena/vasodilator-stimulated phosphoprotein protein family, wh
87 nteraction with Ena/VASP (Drosophila Enabled/Vasodilator-stimulated phosphoprotein) proteins.
88 and the tetramerization motif from the human vasodilator-stimulated phosphoprotein provided much bett
89 1) binding domains of Lpd and the host VASP (vasodilator-stimulated phosphoprotein) recruited to the
90 tream effects, increasing phosphorylation of vasodilator-stimulated phosphoprotein, reducing DNA synt
91 s of the actin-binding protein, cofilin, and vasodilator-stimulated phosphoprotein-regulating conform
92  (PKG)-mediated phosphorylation of the VASP (vasodilator-stimulated phosphoprotein) Ser239 residue wh
93 21680 showed 1) increased phosphorylation of vasodilator-stimulated phosphoprotein that was blocked b
94 l proteins, including the Arp2/3 complex and vasodilator-stimulated phosphoprotein, throughout the ac
95  clusters recruit the actin polymerase VASP (vasodilator-stimulated phosphoprotein) to assemble actin
96 focal adhesion proteins, including zyxin and vasodilator-stimulated phosphoprotein, undergo retrograd
97  prevented NO-induced phosphorylation of the vasodilator-stimulated phosphoprotein VASP both when NO
98  decrease in PKG-mediated phosphorylation of vasodilator-stimulated phosphoprotein (VASP) and a subse
99 r, AKAR4-NES, and induced phosphorylation of vasodilator-stimulated phosphoprotein (VASP) and CREB.
100                                              Vasodilator-stimulated phosphoprotein (VASP) and Ena-VAS
101 RRs were directly responsible for binding of vasodilator-stimulated phosphoprotein (VASP) and for the
102 d in a time-dependent loss of phosphorylated vasodilator-stimulated phosphoprotein (VASP) and signifi
103 ofilin-actin by the last poly-Pro segment of vasodilator-stimulated phosphoprotein (VASP) and the bin
104 toskeletal substrates for PKA, including the vasodilator-stimulated phosphoprotein (VASP) and the pro
105              Molecularly, we have identified vasodilator-stimulated phosphoprotein (VASP) as a new mi
106                                              Vasodilator-stimulated phosphoprotein (VASP) associates
107                                              Vasodilator-stimulated phosphoprotein (VASP) can catalyz
108                               Members of the vasodilator-stimulated phosphoprotein (VASP) family are
109 le zyxin sequences capable of binding to Ena/vasodilator-stimulated phosphoprotein (VASP) family memb
110 associates with members of the Enabled (Ena)/vasodilator-stimulated phosphoprotein (VASP) family of c
111  more recently, as a member of the Ena/human vasodilator-stimulated phosphoprotein (VASP) family of p
112 (SH3), WW, GYF, and Drosophila enabled (Ena)/vasodilator-stimulated phosphoprotein (VASP) homology 1
113 oncentrations nor induced phosphorylation of vasodilator-stimulated phosphoprotein (VASP) in washed h
114                                              Vasodilator-stimulated phosphoprotein (VASP) is a major
115                                              Vasodilator-stimulated phosphoprotein (VASP) is active i
116                                              Vasodilator-stimulated phosphoprotein (VASP) is involved
117  (NO) synthase (eNOS)/protein kinase G (PKG)/vasodilator-stimulated phosphoprotein (VASP) pathway.
118                                          The vasodilator-stimulated phosphoprotein (VASP) plays an im
119                                      The Ena/vasodilator-stimulated phosphoprotein (VASP) protein fam
120                                          Ena/vasodilator-stimulated phosphoprotein (VASP) proteins re
121                                Enabled (Ena)/vasodilator-stimulated phosphoprotein (VASP) proteins re
122 rovide genetic and biochemical evidence that vasodilator-stimulated phosphoprotein (VASP) recruitment
123 ow the multifunctional actin-binding protein vasodilator-stimulated phosphoprotein (VASP) regulates t
124 n this study, we sought to determine whether vasodilator-stimulated phosphoprotein (VASP) signaling i
125 us sequence = FE(D)FPPPPTD(E)E(D)] to tether vasodilator-stimulated phosphoprotein (VASP) to the bact
126 e L. monocytogenes strains unable to recruit vasodilator-stimulated phosphoprotein (VASP) to their su
127                                     Finally, vasodilator-stimulated phosphoprotein (VASP) was identif
128 ctin (F-actin) and of the signaling molecule vasodilator-stimulated phosphoprotein (VASP) was measure
129 rylation and intracellular redistribution of vasodilator-stimulated phosphoprotein (VASP), a critical
130                      Action of Enabled (Ena)/vasodilator-stimulated phosphoprotein (VASP), a family o
131 were induced by macrophage overexpression of vasodilator-stimulated phosphoprotein (VASP), a key down
132                         Targeted deletion of vasodilator-stimulated phosphoprotein (VASP), a key down
133 hances the phosphorylation at Ser-239 of the vasodilator-stimulated phosphoprotein (VASP), a major su
134  expression and phosphorylation state of the vasodilator-stimulated phosphoprotein (VASP), a membrane
135 by AE33 shares similarity with the mammalian vasodilator-stimulated phosphoprotein (VASP), a substrat
136   Microsequencing identified this protein as vasodilator-stimulated phosphoprotein (VASP), an actin b
137 that the actin polymerizing proteins Arp2/3, vasodilator-stimulated phosphoprotein (VASP), and neural
138 lation of actin-based propulsion require the vasodilator-stimulated phosphoprotein (VASP), which bind
139 KG1 resulted in decreased phosphorylation of vasodilator-stimulated phosphoprotein (VASP), which in i
140 red by phosphorylation of the key cGK target vasodilator-stimulated phosphoprotein (VASP).
141 the PKG-GFP fusion proteins colocalized with vasodilator-stimulated phosphoprotein (VASP).
142 a actin-based motility is the involvement of vasodilator-stimulated phosphoprotein (VASP).
143 rated that vinculin p90 binds to IcsA and to vasodilator-stimulated phosphoprotein (VASP).
144 ase G (PKG) and its downstream effector, the vasodilator-stimulated phosphoprotein (VASP).
145 sphorylation of the actin regulatory protein vasodilator-stimulated phosphoprotein (VASP).
146 oteins including the Ena/VASP family member, vasodilator-stimulated phosphoprotein (VASP); however, a
147              Platelet function test results (vasodilator-stimulated phosphoprotein [VASP] phosphoryla
148 lls transfected with the cGKII phosphorylate vasodilator-stimulated phosphoprotein, VASP, after cGMP
149                           Phosphorylation of vasodilator-stimulated phosphoprotein was impaired in HO
150  Ras homolog gene family member A (RhoA) and vasodilator-stimulated phosphoprotein was increased in r
151 k was released, whereas a novel complex with vasodilator-stimulated phosphoprotein was stimulated.
152 aramagnetic resonance and phosphorylation of vasodilator-stimulated phosphoprotein were determined.
153 rotein kinase A (PKA), and the PKA substrate vasodilator-stimulated phosphoprotein were involved in A
154                    The changes in ICAM-1 and vasodilator-stimulated phosphoprotein were recapitulated
155                           Phosphorylation of vasodilator-stimulated phosphoprotein, which is regulate

 
Page Top